News

Braeburn’s BRIXADI™ (buprenorphine) Extended-Release Subcutaneous Injection (CIII) Receives FDA Approval for Moderate to Severe Opioid Use Disorder

by

BRIXADI is the first and only long-acting buprenorphine injectable with both weekly and monthly doses. Patients currently on a transmucosal buprenorphine-containing product can be switched to an equivalent dose of BRIXADI Weekly or Monthly. BRIXADI will be available through a restricted distribution program via the BRIXADI REMS Program and is administered only by a healthcare … Read more

L’intelligence artificielle de ScreenPoint Medical et de Volpara Health démontre sa capacité à prédire le risque de cancer du sein à long terme

by

Des recherches menées par la Mayo Clinic et l’UCSF montrent que la combinaison du Transpara ® Exam Score et du Volpara TruDensity® permet de prédire le risque à long terme de cancer du sein invasif NIMÈGUE, Pays-Bas WELLINGTON, Nouvelle-Zélande, 23 mai 2023 /PRNewswire/ — Des chercheurs de la Mayo Clinic (Rochester, MN) et de l’Université de Californie à San … Read more

IDEMIA IDENTITY AND SECURITY CONTINUES TO LEAD THE DIGITAL CREDENTIAL MARKET WITH LAUNCH OF MISSOURI MOBILE ID

by

Missouri will be first to pilot Mobile ID driver license renewal from anywhere, with an expected full implementation later in 2023. RESTON, Va., May 23, 2023 /PRNewswire/ — IDEMIA Identity and Security (I&S) North America continues to lead the U.S. digital credential market with today’s launch of the Missouri Mobile ID App, in partnership with … Read more

Nirvana Super™ Water Wins Best Functional Drink at Zenith InnoBev Awards

by

NEW YORK, May 23, 2023 /PRNewswire/ — Nirvana Super™ Water has taken top honors at the 2023 Zenith InnoBev Awards winning Best Functional Drink at the London awards ceremony on May 16.  Chosen as the Best Functional Drink from among the leading beverage brands in the world, Nirvana Super™ Water also garnered a finalist position in … Read more

Cognivia erweitert sein Portfolio an prädiktiven Lösungen durch die Einführung von Compl-AI©™, eine innovative Lösung, die das Risiko von Non-Adhärenz und Therapieabbrüchen bei Patienten vorhersagt USA – Deutsch USA – English USA – English

by

Compl-AI©™sagt nachweislich das Risiko von Non-Adhärenz und Therapieabbrüchen voraus. Durch den Einsatz von Compl-AI können die Patientenrekrutierung und Engagementstrategie optimiert werden, um die Patientenergebnisse zu verbessern. Erfahren Sie mehr über Compl-AI in einem Xtalks-Webinar am 21. Juni. MONT-SAINT-GUIBERT, Belgien, 23. Mai 2023 /PRNewswire/ — Cognivia, ein Technologieunternehmen für klinische Studien, das maschinelles Lernen mit einer … Read more

Harvard Pilgrim Health Care Notifies Individuals of Privacy Incident

by

CANTON, Mass., May 23, 2023 /PRNewswire/ — On April 17, 2023, Point32Health, the parent organization of Harvard Pilgrim Health Care (“Harvard Pilgrim“) and Tufts Health Plan, identified a cybersecurity ransomware incident on its computer systems and is working with third-party cybersecurity experts to conduct a thorough investigation into this incident and remediate the situation.  Unfortunately, … Read more

Independent Pharmacy Cooperative Announces New Digital Health Division, Names Ashton Maaraba President

by

SUN PRAIRIE, Wis., May 23, 2023 /PRNewswire/ — Independent Pharmacy Cooperative (IPC) announces the formation of IPC Digital Health, LLC, naming industry healthcare leader, Ashton Maaraba, as President. Maaraba will lead the organization’s Digital Health and Pharmacy Services divisions, reporting directly to Marc Essensa, IPC President and CEO. Maaraba’s role is to future-proof member pharmacies … Read more

Blue Shield of California Recognized as One of the 50 Most Community-Minded Companies in the United States

by

Second time in three years that Civic 50 honors the nonprofit health plan’s commitment to Stand For What’s Right OAKLAND, Calif., May 23, 2023 /PRNewswire/ — Blue Shield of California has been named a 2023 honoree of The Civic 50 by Points of Light, the world’s largest nonprofit organization dedicated to accelerating people-powered change. Now in … Read more

Need to Reduce Human Error and Manual Work Bolsters Adoption

by

DUBLIN, May 23, 2023 /PRNewswire/ — The “Laboratory Automation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to  ResearchAndMarkets.com’s offering. The global laboratory automation market size reached US$ 6.1 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 9.4 Billion by 2028, exhibiting a … Read more